Last reviewed · How we verify
NCT02575599: DiaWeb
Web-based Guided Self-Determination Intervention for Adults With Type 2 Diabetes in General Practice
NA trial testing Guided self-determination programme (GSD) in Type 2 Diabetes in 172 participants. Status unknown.
1 September 2019
Quick facts
| Lead sponsor | University of Stavanger |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 172 |
| Start date | 1 September 2018 |
| Primary completion | 1 September 2019 |
| Estimated completion | 1 January 2020 |
Drugs / interventions tested
- Guided self-determination programme (GSD)
Conditions studied
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
Sponsor
University of Stavanger
Who can join
18 and older, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall aim of this study is to assess the effectiveness of a web-based Guided Self-Determination program among adults with type 2 diabetes in general practice in order to improve diabetes self-management behaviours and HbA1c through enhanced patient activation, self-care competence, and autonomy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessment of a web-based Guided Self-Determination intervention for adults with type 2 diabetes in general practice: a study protocol.
Karlsen B, Oftedal B, Stangeland Lie S, Rokne B, et al · · 2016 · cited 11× · PMID 27965253 · DOI 10.1136/bmjopen-2016-013026
Verify or expand the search:
- PubMed search for NCT02575599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type 2 Diabetes
Currently open trials in the same condition.
- NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07254689 — The Food for Health Study · NA · recruiting
- NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting
Other University of Stavanger trials
Trials by the same sponsor.
- NCT07504042 — Resilience Toolbox Intervention in Elderly Care · NA · not yet recruiting
- NCT05750953 — Nurse-assisted Intervention "eHealth@ Hospital -2-home" · NA · active not recruiting
- NCT05837728 — Health Determinants in Older Adults Living At Home · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02575599 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Stavanger
- Last refreshed: 2 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02575599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing